Shalby has informed that pursuant to regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shalby has informed that the Company had a conference call on 16th April 2020 with the investors/ analyst group hosted by Edelweiss to discuss current scenario and impact on healthcare industry in connection with ongoing COVID-19 pandemic.
The above information is a part of company’s filings submitted to BSE.